Schoeneck, Germany

Wilfried Bluemke


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wilfried Bluemke: Innovator in Omega-Amino Fatty Acids

Introduction

Wilfried Bluemke is a notable inventor based in Schoeneck, Germany. He has made significant contributions to the field of biochemistry, particularly in the production of omega-amino fatty acids. His innovative work has led to the development of a unique whole cell catalyst that enhances the efficiency of fatty acid conversion processes.

Latest Patents

Wilfried Bluemke holds a patent for the "Production of omega-amino fatty acids." This invention involves a whole cell catalyst that expresses a recombinant α-dioxygenase or a combination of a recombinant fatty acid reductase and a phosphopantetheinyl transferase. The catalyst also expresses a transaminase, which is crucial for converting fatty acids, ω-hydroxy fatty acids, ω-oxo fatty acids, or their monoesters into amines. The method includes oxidation of these compounds, followed by a series of reactions that ultimately yield valuable amine products.

Career Highlights

Wilfried Bluemke is associated with Evonik Degussa GmbH, a leading company in specialty chemicals. His work at Evonik has allowed him to focus on innovative solutions in the field of fatty acid chemistry. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his area of expertise.

Collaborations

Throughout his career, Wilfried has collaborated with talented professionals such as Steffen Schaffer and Jasmin Gielen. These collaborations have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Wilfried Bluemke's contributions to the production of omega-amino fatty acids exemplify the impact of innovative thinking in biochemistry. His work continues to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…